A Painful Pill to Swallow

Roddy Boyd of Storm King Reports makes the case that Intra-Cellular Therapies (ITCI) has failed to properly disclose a severe adverse reaction to its blockbuster drug, Caplyta.

A Toolbox of Accounting Tricks

“JR” of Jehoshaphat Research makes the case that Techtronic Industries (669 HK) has engaged in a practice called “snowballing” to maintain margin growth that can be classified as none other than statistically impossible.